Effect of spironolactone on monocyte subsets in atrial fibrillation: IMPRESS-AF randomised controlled trial. [PDF]
Shahid F +3 more
europepmc +1 more source
Cardiac Magnetic Resonance Assessment of Interstitial Myocardial Fibrosis and Cardiomyocyte Hypertrophy in Hypertensive Mice Treated With Spironolactone [PDF]
Otávio R. Coelho‐Filho +6 more
openalex +1 more source
Correction: Clinical evaluation of a novel fixed-dose combination tablet (Sentorpil<sup>®</sup> ForteGold) versus compounded powdered medications in dogs with myxomatous mitral valve disease: a randomized, double-blind study. [PDF]
Park J, Lee J, Lee SJ, Hyun C.
europepmc +1 more source
Sodium zirconium cyclosilicate, hyperkalaemia, and spironolactone optimization in heart failure with reduced ejection fraction: The REALIZE-K open-label run-in phase. [PDF]
Petrie MC +26 more
europepmc +1 more source
Renal sodium handling and neurohumoral systems in patients with cirrhosis in sitting posture [PDF]
Gerbes, Alexander L. +3 more
core +1 more source
Use of Spironolactone for the Treatment of Heart Failure With Preserved Ejection Fraction: Efficacy and Clinical Implications in Light of Recent Evidence. [PDF]
Maharjan R +6 more
europepmc +1 more source
Concerns Regarding Renal Function Claims in Low-Dose Spironolactone Study. [PDF]
Helvacı Ö, Helvacı BC.
europepmc +1 more source
Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis. [PDF]
Liu X, Ding R, Zhang A.
europepmc +1 more source

